NCT07610122 Validation of the Turkish Version of the S3-NIV Questionnaire
| NCT ID | NCT07610122 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul Saglik Bilimleri University |
| Condition | Respiratory Insufficiency |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-05-21 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2026-05-21 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the psychometric properties, including reliability and validity, of the Turkish version of the Severe Respiratory Insufficiency Questionnaire for Non-Invasive Ventilation (S3-NIV). The S3-NIV is a specific tool designed to assess difficulties and compliance in patients receiving home non-invasive ventilation. A total of 120 stable patients using home NIV for at least 3 months will be enrolled across multiple centers.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with chronic respiratory failure requiring home non-invasive ventilation (NIV). * Using a home NIV device for at least 3 months. * Being in a clinically stable phase (no exacerbation or hospitalization in the last 1 month). * Able to understand and answer the questionnaire. * Provided written informed consent. Exclusion Criteria: * Acute respiratory failure or clinical instability. * Severe cognitive impairment or psychiatric disorders preventing reliable communication. * Active malignancy or terminal illness with a short life expectancy. * Refusal to provide informed consent.
Contact & Investigator
Ipek Ozmen, Prof.
PRINCIPAL INVESTIGATOR
Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital
Frequently Asked Questions
Who can join the NCT07610122 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Respiratory Insufficiency. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07610122 currently recruiting?
Yes, NCT07610122 is actively recruiting participants. Contact the research team at fztdlkunsal@gmail.com for enrollment information.
Where is the NCT07610122 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07610122 clinical trial?
NCT07610122 is sponsored by Istanbul Saglik Bilimleri University. The principal investigator is Ipek Ozmen, Prof. at Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital. The trial plans to enroll 120 participants.